Summit Therapeutics plc
Summit Therapeutics plc

Summit Therapeutics plc

hand in laptop pointing to email icon

Your dream job…could be 1 update away

Summit Therapeutics plc Jobs and Salary Info

Find High Paying Jobs, Compensation Information and Expert Network Connections at Summit Therapeutics plc

Summit Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines to treat rare diseases with high unmet medical need. The company's lead product candidate, Ridinilazole, is a precision antibiotic that has the potential to treat Clostridium difficile infection (CDI) with a superior clinical profile compared to existing CDI treatments. Summit Therapeutics is also developing a pipeline of additional product candidates targeting genetic diseases and other indications.


Market Cap$842.6 million
Revenue$1 million
5 Year Trendarrow trend up+9910%
pie chartAnnual Report
stats icon
Total value of jobs:
stats icon
Average Pay:
stats icon
% Masters: